NO20004914D0 - En fremgangsmÕte for Õ fremstille ikke-patogene, infeksiøse pankreatiske nekrosevirus (IPNV) fra syntetiske RNA-transkripter - Google Patents

En fremgangsmÕte for Õ fremstille ikke-patogene, infeksiøse pankreatiske nekrosevirus (IPNV) fra syntetiske RNA-transkripter

Info

Publication number
NO20004914D0
NO20004914D0 NO20004914A NO20004914A NO20004914D0 NO 20004914 D0 NO20004914 D0 NO 20004914D0 NO 20004914 A NO20004914 A NO 20004914A NO 20004914 A NO20004914 A NO 20004914A NO 20004914 D0 NO20004914 D0 NO 20004914D0
Authority
NO
Norway
Prior art keywords
ipnv
rna transcripts
synthetic rna
necrosis virus
preparing non
Prior art date
Application number
NO20004914A
Other languages
English (en)
Other versions
NO329660B1 (no
NO20004914L (no
Inventor
Vikram N Vakharia
Kun Yao
Original Assignee
Univ Maryland Biotech Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland Biotech Inst filed Critical Univ Maryland Biotech Inst
Publication of NO20004914D0 publication Critical patent/NO20004914D0/no
Publication of NO20004914L publication Critical patent/NO20004914L/no
Publication of NO329660B1 publication Critical patent/NO329660B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2720/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20004914A 1998-03-31 2000-09-29 cDNA, RNA, vektor, vertcelle, kimaert ikke-patogent akvatisk birnavirus, levende ikke-patogene IPNV, vaksine samt fremgangsmate for fremstilling NO329660B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8017898P 1998-03-31 1998-03-31
PCT/US1999/004285 WO1999050419A2 (en) 1998-03-31 1999-03-31 A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts

Publications (3)

Publication Number Publication Date
NO20004914D0 true NO20004914D0 (no) 2000-09-29
NO20004914L NO20004914L (no) 2000-11-23
NO329660B1 NO329660B1 (no) 2010-11-22

Family

ID=22155757

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20004914A NO329660B1 (no) 1998-03-31 2000-09-29 cDNA, RNA, vektor, vertcelle, kimaert ikke-patogent akvatisk birnavirus, levende ikke-patogene IPNV, vaksine samt fremgangsmate for fremstilling
NO20082682A NO20082682L (no) 1998-03-31 2008-06-16 En fremgangsmate for a fremstille ikke-patogene, infeksiose pancreatiske nekrosevirus (IPNC) fra syntetisk RNA-transkripter

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20082682A NO20082682L (no) 1998-03-31 2008-06-16 En fremgangsmate for a fremstille ikke-patogene, infeksiose pancreatiske nekrosevirus (IPNC) fra syntetisk RNA-transkripter

Country Status (6)

Country Link
US (1) US6274147B1 (no)
AU (1) AU3353599A (no)
CA (1) CA2324478C (no)
DK (1) DK200001374A (no)
NO (2) NO329660B1 (no)
WO (1) WO1999050419A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596280B1 (en) * 1997-07-31 2003-07-22 University Of Maryland Biotechnology Institute Method for generating birnavirus from synthetic RNA transcripts
US20040001863A1 (en) * 1998-12-03 2004-01-01 Shau-Chi Chi Immortal cell line derived from grouper Epinephelus coioides and its applications therein
US6630456B2 (en) * 1999-11-23 2003-10-07 Academia Sinica Regulation of apoptosis in aquatic organisms by aquabirnavirus
CA2457349A1 (en) * 2001-08-10 2003-02-20 University Of Maryland Biotechnology Institute Sub-unit vaccine for infectious pancreatic necrosis virus
WO2004003143A2 (en) * 2002-06-26 2004-01-08 Advanced Bionutrition Corporation Viruses and virus-like particles for multiple antigen and target display
TWI347364B (en) 2003-02-19 2011-08-21 Novartis Ag Inactivated nodavirus vaccine
ES2217967B1 (es) * 2003-03-31 2006-01-01 Consejo Sup. Investig. Cientificas Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
ES2307345B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2307346B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
EP1773858B1 (en) 2004-05-27 2016-06-22 Janssen Biotech, Inc. Cynomolgus prostate specific antigen
AU2005329405A1 (en) * 2004-06-15 2006-09-28 Centocor, Inc. Method for screening agents against human prostate disease
US7244432B2 (en) * 2004-12-08 2007-07-17 University Of Maryland Biotechnology Institute Infectious bursal disease virus (IBDV) variant from Georgia
DE102005010288A1 (de) * 2005-03-02 2006-09-07 Riemser Arzneimittel Ag Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
WO2011012999A1 (en) 2009-07-31 2011-02-03 Novartis Ag Reverse genetics systems
NO332608B1 (no) * 2011-03-16 2012-11-19 Norwegian School Of Veterinary Science Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk
CN103937912B (zh) * 2014-05-13 2016-07-20 吴斌 用于检测传染性胰脏坏死病毒的lamp引物组合物及其应用
JP2022543423A (ja) 2019-08-09 2022-10-12 ナットクラッカー セラピューティクス， インコーポレイテッド 治療用組成物から材料を除去するための製造方法および装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
EP0887412B1 (en) * 1997-05-26 2003-10-15 Akzo Nobel N.V. Recombinant birnavirus vaccine
US6231868B1 (en) * 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
US6274147B1 (en) 2001-08-14
NO20082682L (no) 2000-11-23
WO1999050419A3 (en) 1999-11-18
CA2324478A1 (en) 1999-10-07
NO329660B1 (no) 2010-11-22
DK200001374A (da) 2000-11-23
NO20004914L (no) 2000-11-23
CA2324478C (en) 2011-08-23
WO1999050419A2 (en) 1999-10-07
AU3353599A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
NO20004914D0 (no) En fremgangsmÕte for Õ fremstille ikke-patogene, infeksiøse pankreatiske nekrosevirus (IPNV) fra syntetiske RNA-transkripter
ZA200300410B (en) Method of producing infectious reovirus.
DK1157615T3 (da) Fremgangsmåde til fjernelse af ubehagelige, flygtige stoffer fra lecithin
DE60020163D1 (de) Fotomaske, verfahren zu ihrer herstellung
ID25570A (id) Metoda penghilangan gas secara vakum untuk aliran kaca leleh
ZA200110473B (en) Respiratory syncytial virus replication inhibitors.
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
BR0002614B1 (pt) processo para recuperaÇço de diàxido de carbono.
FI20002148A (fi) Menetelmä tuotteiden talteenottamiseksi
DE50213353D1 (de) Verfahren zur herstellung hochmolekularer, vernetzter polyvinylbutyrale
HK1070440A1 (en) A method of, and system for, heuristically detecting viruses in executable code by detecting files which have been maliciosly altered
BR0011597B1 (pt) método para separar um composto de alto peso molecular contendo lactona.
SE9901123L (sv) Förfarande för effektiv synkronisering i ett kommunikationssystem
DK1456281T3 (da) Fremgangsmåde til genvinding af en polymer fra en oplösning
DK1210351T3 (da) Fremgangsmåde til separering af lactonholdige forbindelser med höj molekylvægt
MXPA03004298A (es) Metodo para transmitir optimamente virus a masa de tumor solido.
FI20002134A0 (fi) Koodisynkronointimenetelmä ja vastaanotin
DE60045077D1 (de) Hitzebeständige, expandierte graphitplatten und verfahren zu deren herstellung
DE50003433D1 (de) 2-Methyl-4-phenyl-1, 3-dioxolan
DK1453527T3 (da) Fremgangsmåde til udvinding af estrogener fra hoppeurin
DE50106637D1 (de) Verfahren zur herstellung von gut benetzbaren, wasserlöslichen, pulverförmigen, mindestens alkylierten, nicht-ionischen celluloseethern
AR025435A1 (es) Metodo para sintetizar mezclas de oligosacaridos derivados de (fosfato-ribosa-ribitol)n o de (ribosa-ribitol-fosfato)n y disacaridos intermedios de los mismos
AU6898101A (en) Method for producing 2-chloro-5-chloromethyl-1,3-thiazole
ITRM20010477A1 (it) Procedimento per la produzione o rigenerazione di un pneumatico, comepure dispositivo di riporto di battistrada.
DK1265908T3 (da) Fremgangsmåde til fremstilling af derivater af 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin A ud fra 9-deoxo-9(Z)-hydroxyiminoerythromycin A

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees